Latest Pivotal bioVenture Partners Investment Advisor LLC Stock Portfolio
$279Million– No. of Holdings #13
Pivotal bioVenture Partners Investment Advisor LLC Performance:
2026 Q1: 9.98%YTD: 9.98%2025: 25.79%
Performance for 2026 Q1 is 9.98%, and YTD is 9.98%, and 2025 is 25.79%.
About Pivotal bioVenture Partners Investment Advisor LLC and 13F Hedge Fund Stock Holdings
On 2026-05-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Pivotal bioVenture Partners Investment Advisor LLC reported an equity portfolio of $279.8 Millions as of 31 Mar, 2026.
The top stock holdings of Pivotal bioVenture Partners Investment Advisor LLC are PCVX, , . The fund has invested 28.5% of it's portfolio in VAXCYTE INC and 16% of portfolio in OCULIS HOLDING AG.
The fund managers got completely rid off RALLYBIO CORP (RLYB) stocks. They significantly reduced their stock positions in BOLT BIOTHERAPEUTICS INC (BOLT), OCULIS HOLDING AG and ARCUTIS BIOTHERAPEUTICS INC (ARQT). Pivotal bioVenture Partners Investment Advisor LLC opened new stock positions in AVALO THERAPEUTICS INC (AVTX) and RALLYBIO CORP (RLYB). The fund showed a lot of confidence in some stocks as they added substantially to TREVI THERAPEUTICS INC (TRVI).
The top stock holdings of Pivotal bioVenture Partners Investment Advisor LLC are PCVX, , . The fund has invested 28.5% of it's portfolio in VAXCYTE INC and 16% of portfolio in OCULIS HOLDING AG.
The fund managers got completely rid off RALLYBIO CORP (RLYB) stocks. They significantly reduced their stock positions in BOLT BIOTHERAPEUTICS INC (BOLT), OCULIS HOLDING AG and ARCUTIS BIOTHERAPEUTICS INC (ARQT). Pivotal bioVenture Partners Investment Advisor LLC opened new stock positions in AVALO THERAPEUTICS INC (AVTX) and RALLYBIO CORP (RLYB). The fund showed a lot of confidence in some stocks as they added substantially to TREVI THERAPEUTICS INC (TRVI).
Pivotal bioVenture Partners Investment Advisor LLC Equity Portfolio Value
Last Reported on: 14 May, 2026
Pivotal bioVenture Partners Investment Advisor LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Pivotal bioVenture Partners Investment Advisor LLC made a return of 9.98% in the last quarter. In trailing 12 months, it's portfolio return was 77.59%.
- Performance
- S&P 500
New Buys
| Ticker | $ Bought |
|---|---|
| avalo therapeutics inc | 4,418,280 |
| rallybio corp | 2,696,190 |
New stocks bought by Pivotal bioVenture Partners Investment Advisor LLC
Additions
| Ticker | % Inc. |
|---|---|
| trevi therapeutics inc | 23.63 |
Additions to existing portfolio by Pivotal bioVenture Partners Investment Advisor LLC
Reductions
| Ticker | % Reduced |
|---|---|
| bolt biotherapeutics inc | -54.98 |
| oculis holding ag | -26.58 |
| arcutis biotherapeutics inc | -0.79 |
Pivotal bioVenture Partners Investment Advisor LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| rallybio corp | -1,649,590 |
Pivotal bioVenture Partners Investment Advisor LLC got rid off the above stocks
Sector Distribution
Pivotal bioVenture Partners Investment Advisor LLC has about 55.5% of it's holdings in Healthcare sector.
- Healthcare
- Others
| Sector | % |
|---|---|
| Healthcare | 55.5 |
| Others | 44.5 |
Market Cap. Distribution
Pivotal bioVenture Partners Investment Advisor LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
- MID-CAP
- UNALLOCATED
- SMALL-CAP
- MICRO-CAP
| Category | % |
|---|---|
| MID-CAP | 45.6 |
| UNALLOCATED | 44.5 |
| SMALL-CAP | 7.3 |
| MICRO-CAP | 1.6 |
Stocks belong to which Index?
About 48.2% of the stocks held by Pivotal bioVenture Partners Investment Advisor LLC either belong to S&P 500 or RUSSELL 2000 index.
- Others
- RUSSELL 2000
| Index | % |
|---|---|
| Others | 51.8 |
| RUSSELL 2000 | 48.2 |
Pivotal bioVenture Partners Investment Advisor LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Pivotal bioVenture Partners Investment Advisor LLC
Pivotal bioVenture Partners Investment Advisor LLC has 13 stocks in it's portfolio. About 98.3% of the portfolio is in top 10 stocks. proved to be the most loss making stock for the portfolio. PCVX was the most profitable stock for Pivotal bioVenture Partners Investment Advisor LLC last quarter.
Last Reported on: 14 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ARQT | arcutis biotherapeutics inc | 11.42 | 1,355,890 | 31,944,800 | reduced | -0.79 | ||
| AVTX | avalo therapeutics inc | 1.58 | 295,933 | 4,418,280 | new | |||
| BOLT | bolt biotherapeutics inc | 0.06 | 42,581 | 172,027 | reduced | -54.98 | ||
| IMNM | immunome inc | 5.73 | 732,512 | 16,020,000 | unchanged | 0.00 | ||
| PCVX | vaxcyte inc | 28.50 | 1,372,420 | 79,751,600 | unchanged | 0.00 | ||
| RLYB | rallybio corp | 0.96 | 300,579 | 2,696,190 | new | |||
| RLYB | rallybio corp | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| RXRX | recursion pharmaceuticals in | 0.65 | 595,518 | 1,828,240 | unchanged | 0.00 | ||
| TRVI | trevi therapeutics inc | 6.62 | 1,553,730 | 18,536,000 | added | 23.63 | ||
| oculis holding ag | 15.97 | 1,680,280 | 44,678,700 | reduced | -26.58 | |||
| evommune inc | 15.83 | 1,926,940 | 44,300,400 | unchanged | 0.00 | |||
| maplight therapeutics inc | 4.44 | 611,447 | 12,430,700 | unchanged | 0.00 | |||
| zenas biopharma inc | 4.14 | 591,991 | 11,573,400 | unchanged | 0.00 | |||
| bioage labs inc | 4.08 | 653,374 | 11,427,500 | unchanged | 0.00 | |||